MARC details
000 -LEADER |
fixed length control field |
03246cam a22004094a 4500 |
001 - CONTROL NUMBER |
control field |
2003022824 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
DLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20190729103004.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
031016s2005 cau b s001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2003022824 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0520221516 (cloth : alk. paper) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(DNLM)101194381 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DNLM/DLC |
Transcribing agency |
DLC |
Modifying agency |
DLC |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
EY8Z |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
QP572.T4 |
Item number |
H635 2005 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
WJ 875 |
Item number |
H682t 2005 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615/.36 |
Edition number |
22 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Hoberman, John M. |
Fuller form of name |
(John Milton), |
Dates associated with a name |
1944- |
245 10 - TITLE STATEMENT |
Title |
Testosterone dreams : |
Remainder of title |
rejuvenation, aphrodisia, doping / |
Statement of responsibility, etc. |
John Hoberman. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Berkeley : |
Name of publisher, distributor, etc. |
University of California Press, |
Date of publication, distribution, etc. |
c2005. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
381 p. ; |
Dimensions |
23 cm. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references (p. 287-358) and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Pharmacology and our human future -- Hormone therapy and the new medical paradigm enhancements : where are the limits? -- Testosterone as therapy and myth -- "Psychic steroids" : Prozac as a performance-enhancing drug -- Back to the future : the sex hormone market from organotherapy to "andro" -- The aphrodisiac that failed : why testosterone did not become a mass sex therapy -- What they did to women : the origins of sex therapy -- Sex before kinsey : what doctors and patients did not know -- Hormones and the state : sex and marital stability -- Patriarchal sex therapy : curing "frigidity" with hormones -- Reorienting male desire : curing homosexuals with sex hormones -- Aphrodisia for the masses? -- The secret life of testosterone therapy -- The mainstreaming of testosterone -- Celebrating testosterone -- Hormone therapy and the discovery of sexual deficiency -- Preserving the feminine essence : estrogen and menopause -- Does the male menopause exist? -- "Outlaw" biomedical innovations : hormone therapy and beyond -- Hormone therapy and cosmetic procedures : the new medical ethos -- Offshore entrepreneurial medicine : from embryos to cloning -- Medical populism and outlaw medicine : fertility techniques and medical marijuana -- Hormone therapists and hormone evangelists -- Hormone therapy for athletes : doping as social transgression -- Introduction -- Doping before steroids : clean amateurs and doped professionals -- The sports physician as hormone therapist -- The entrepreneurial physician -- Medical ethics -- The doctor-athlete relationship -- The patient as athlete, the athlete as patient -- Public responses to doping -- A war against drugs? -- The politics of hormone doping in sport -- International doping control before reform -- Sportive nationalism and doping -- International doping control after reform -- A war on drugs? -- Athletes and the doping of everyday life -- Athletic doping and the human future -- Epilogue, testosterone as a way of life. |
596 ## - |
-- |
1 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Testosterone. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Hormone therapy. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Menopause |
General subdivision |
Hormone therapy. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Testosterone |
General subdivision |
Therapeutic use. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Testosterone |
General subdivision |
Physiological effect. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Longevity. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Aphrodisiacs. |
856 41 - ELECTRONIC LOCATION AND ACCESS |
Public note |
Table of contents |
Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/toc/ecip0410/2003022824.html">http://www.loc.gov/catdir/toc/ecip0410/2003022824.html</a> |
948 ## - LOCAL PROCESSING INFORMATION (OCLC); SERIES PART DESIGNATOR (RLIN) |
Series part designator, SPT (RLIN) |
u175632 |
949 ## - LOCAL PROCESSING INFORMATION (OCLC) |
h |
EY8Z |
i |
33039000757673 |
903 ## - LOCAL DATA ELEMENT C, LDC (RLIN) |
a |
9837 |